Anthony John Day - Curriculum Vitae#

• 1985 B.A.Hons Chemistry, Exeter College, University of Oxford, UK
  
• 1988 D.Phil., Wolfson College, University of Oxford, UK
  
• 1989 M.A., Exeter College, University of Oxford, UK
  
  

Current Grant Income:

~£5.4M (ARUK (Programme/Project Grant), BBSRC (2 CASE PhD Studentships with Eden Biodesign (UK) and Farfield Group Ltd (UK)), BHF (PhD Studentship), EPSRC (Novel Technologies for Stem Cell Science Award), Fight for Sight (Clinical Fellowship), Manchester/A*STAR PhD Studentship, MRC (DPFS, Project Grant, 2 PhD Studentships).

Current major projects:

• Protective functions of TSG-6 in joint tissues
  
• Complement factor H in age-related macular degeneration (AMD)
  
• TSG-6 and inter-alpha-inhibitor in female fertility
  
• Biophysical characterisation of glycosaminoglycan-protein interactions
  

Publications:

141 in total since 1986 (69 1st/last/corresponding author); H-index = 44.

Other activities:

• Invited speaker/session chair at 38 meetings (incl. 6 Gordon Research Conferences (GRCs)); 13 during 2007-2012, including invited speaker at two different GRCs (Proteoglycans 2008/2012, Cartilage Biology & Pathology 2009) and at XXIst FECTS 2008 (plenary), 20th International Symposium on Glycoconjugates 2009 (plenary) and 7th International Conference on Proteoglycans.
• Over 70 other talks and seminars [30 during 2007-2012 including in Australia, Austria, Denmark, Germany (2), Italy (2), Spain, USA (5)]; 210 posters.
  
• Supervised 19 DPhil/PhD students to completion since 1993 [15 (DPhil) at University of Oxford]. Currently: 6 PhD students at University of Manchester and 1 at Clinical Institute Humanitas, Milan, Italy (Open University).
  
• Co-inventor on 5 patent applications; 1 granted (US 7,829,301 B2)
  
• Consultant and Scientific Advisory Board of Temple Therapeutics, USA (2011- )
  
• Consultant to Echelon Biosciences, USA (2011- )
  
• Technical Expert for Harrison Goddard Foote (2009)
  
• Scientific Advisory Board, Iduron, UK (2008- )
  
• Consultant to Plasso Technology, UK (2003- 2006)
  
• Technical consultant to Amylin Pharmaceuticals, USA (1988-1991)